Medtech Archives - Page 96 of 98 - Life Sciences Times

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

June 6, 2025

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

June 4, 2025

THIS WEEK'S STORIES

TriLink and Quantoom Partner to Expand Access to mRNA Vaccines and Therapeutics Globally

June 3, 2025

Dr. Drew Kurtzman Joins AndHealth Dermatology, Now Seeing Patients in Ohio and Kentucky

June 6, 2025

Pheast Therapeutics Earns FDA Fast Track Designation for Experimental Ovarian Cancer Therapy PHST001

June 3, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

HistoSonics Completes Enrollment in Pivotal Trial Testing Non-Invasive Kidney Tumor Treatment

Study Highlights Major Advantages of PharmaJet’s Needle-Free Tropis® ID System in Nigeria’s Polio Vaccination Efforts

Foldax Receives Indian Approval for First-Ever Commercial Polymer Mitral Heart Valve

Gore Launches 0.5 mL Silicone-Free Plunger for Ophthalmic Pre-Filled Syringes

ZOLL and Simon’s Heart Donate AEDs to 32 Youth Organizations Nationwide in Honor of CPR and AED Awareness Week

Most Read

Otsuka’s Sibeprenlimab Shows Strong Results in Phase 3 Trial for IgA Nephropathy

Suffolk Unveils White Paper to Drive Climate Tech Adoption in Construction Industry

Tracer Biotechnologies Partners with QIAGEN to Expand Blood-Based Cancer Testing

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

EDITOR PICKS

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

THIS WEEK'S STORIES

TriLink and Quantoom Partner to Expand Access to mRNA Vaccines and Therapeutics Globally

Dr. Drew Kurtzman Joins AndHealth Dermatology, Now Seeing Patients in Ohio and Kentucky

Pheast Therapeutics Earns FDA Fast Track Designation for Experimental Ovarian Cancer Therapy PHST001

POPULAR CATEGORY

ABOUT US

FOLLOW US